JP2009520463A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009520463A5 JP2009520463A5 JP2008542539A JP2008542539A JP2009520463A5 JP 2009520463 A5 JP2009520463 A5 JP 2009520463A5 JP 2008542539 A JP2008542539 A JP 2008542539A JP 2008542539 A JP2008542539 A JP 2008542539A JP 2009520463 A5 JP2009520463 A5 JP 2009520463A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- polypeptide
- heptapeptide
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002773 nucleotide Substances 0.000 claims 136
- 125000003729 nucleotide group Chemical group 0.000 claims 136
- 108090000765 processed proteins & peptides Proteins 0.000 claims 132
- 229920001184 polypeptide Polymers 0.000 claims 129
- 102000004196 processed proteins & peptides Human genes 0.000 claims 129
- 230000027455 binding Effects 0.000 claims 121
- 239000000203 mixture Substances 0.000 claims 79
- 125000003275 alpha amino acid group Chemical group 0.000 claims 63
- 125000000539 amino acid group Chemical group 0.000 claims 60
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 49
- 239000011701 zinc Substances 0.000 claims 49
- 229910052725 zinc Inorganic materials 0.000 claims 49
- 238000006467 substitution reaction Methods 0.000 claims 27
- 229910052717 sulfur Inorganic materials 0.000 claims 27
- 229910052739 hydrogen Inorganic materials 0.000 claims 24
- 102000040430 polynucleotide Human genes 0.000 claims 23
- 108091033319 polynucleotide Proteins 0.000 claims 23
- 239000002157 polynucleotide Substances 0.000 claims 23
- 229910052722 tritium Inorganic materials 0.000 claims 16
- 108090000623 proteins and genes Proteins 0.000 claims 12
- 239000003937 drug carrier Substances 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 108091023040 Transcription factor Proteins 0.000 claims 10
- 102000040945 Transcription factor Human genes 0.000 claims 10
- 229910052757 nitrogen Inorganic materials 0.000 claims 9
- 150000007523 nucleic acids Chemical group 0.000 claims 9
- 230000002103 transcriptional effect Effects 0.000 claims 9
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims 7
- 102000003964 Histone deacetylase Human genes 0.000 claims 6
- 108090000353 Histone deacetylase Proteins 0.000 claims 6
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 6
- 238000010494 dissociation reaction Methods 0.000 claims 6
- 230000005593 dissociations Effects 0.000 claims 6
- 150000001413 amino acids Chemical class 0.000 claims 4
- 230000010076 replication Effects 0.000 claims 4
- 125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 claims 3
- 125000000570 L-alpha-aspartyl group Chemical group [H]OC(=O)C([H])([H])[C@]([H])(N([H])[H])C(*)=O 0.000 claims 3
- 125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 claims 3
- 125000000010 L-asparaginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(=O)N([H])[H] 0.000 claims 3
- 125000000415 L-cysteinyl group Chemical group O=C([*])[C@@](N([H])[H])([H])C([H])([H])S[H] 0.000 claims 3
- 125000003338 L-glutaminyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C(=O)N([H])[H] 0.000 claims 3
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 claims 3
- 125000002061 L-isoleucyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](C([H])([H])[H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 3
- 125000001176 L-lysyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C([H])([H])C([H])([H])C(N([H])[H])([H])[H] 0.000 claims 3
- 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 claims 3
- 125000000769 L-threonyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](O[H])(C([H])([H])[H])[H] 0.000 claims 3
- 125000002707 L-tryptophyl group Chemical group [H]C1=C([H])C([H])=C2C(C([C@](N([H])[H])(C(=O)[*])[H])([H])[H])=C([H])N([H])C2=C1[H] 0.000 claims 3
- 125000003580 L-valyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(C([H])([H])[H])(C([H])([H])[H])[H] 0.000 claims 3
- 102100025169 Max-binding protein MNT Human genes 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 238000000302 molecular modelling Methods 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 229910052698 phosphorus Inorganic materials 0.000 claims 3
- 108091006106 transcriptional activators Proteins 0.000 claims 3
- 108091008023 transcriptional regulators Proteins 0.000 claims 3
- 108091006107 transcriptional repressors Proteins 0.000 claims 3
- 230000004568 DNA-binding Effects 0.000 claims 2
- 101710185494 Zinc finger protein Proteins 0.000 claims 2
- 102100023597 Zinc finger protein 816 Human genes 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 108010077805 Bacterial Proteins Proteins 0.000 claims 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims 1
- 101710163270 Nuclease Proteins 0.000 claims 1
- 108700001094 Plant Genes Proteins 0.000 claims 1
- 108700005077 Viral Genes Proteins 0.000 claims 1
- 230000003197 catalytic effect Effects 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 102000037983 regulatory factors Human genes 0.000 claims 1
- 108091008025 regulatory factors Proteins 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74052505P | 2005-11-28 | 2005-11-28 | |
| PCT/US2006/061289 WO2007062422A2 (en) | 2005-11-28 | 2006-11-28 | Zinc finger binding domains for tnn |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009520463A JP2009520463A (ja) | 2009-05-28 |
| JP2009520463A5 true JP2009520463A5 (enExample) | 2010-01-14 |
Family
ID=38068069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008542539A Pending JP2009520463A (ja) | 2005-11-28 | 2006-11-28 | Ｔｎｎのための亜鉛フィンガー結合ドメイン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7833784B2 (enExample) |
| EP (1) | EP1963499A4 (enExample) |
| JP (1) | JP2009520463A (enExample) |
| CA (1) | CA2631422A1 (enExample) |
| WO (1) | WO2007062422A2 (enExample) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7329728B1 (en) * | 1999-10-25 | 2008-02-12 | The Scripps Research Institute | Ligand activated transcriptional regulator proteins |
| CA2631422A1 (en) | 2005-11-28 | 2007-05-31 | The Scripps Research Institute | Zinc finger binding domains for tnn |
| US8168181B2 (en) | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
| JP5173838B2 (ja) | 2006-02-13 | 2013-04-03 | アレシア・バイオセラピューティクス・インコーポレーテッド | 骨リモデリングのプロセスと関係があるポリヌクレオチドおよびポリペプチド配列 |
| US20090081786A1 (en) * | 2006-06-30 | 2009-03-26 | Viktoria Kheifets | Peptide sequences for modulation of protein kinase C |
| ES2585157T3 (es) * | 2007-09-27 | 2016-10-04 | Dow Agrosciences Llc | Proteínas de dedo de cinc de diseño que se dirigen a los genes de 5-enolpiruvil shikimato-3-fosfato sintasa |
| PL2274430T3 (pl) | 2008-04-30 | 2017-09-29 | Sanbio Inc | Komórki regenerujące nerwy ze zmianami w metylacji DNA |
| WO2010056808A2 (en) * | 2008-11-12 | 2010-05-20 | The Regents Of The University Of California | Compositions and methods for re-programming and re-differentiating cells |
| NZ598457A (en) | 2009-08-03 | 2014-06-27 | Recombinetics Inc | Methods and compositions for targeted gene modification |
| US8956828B2 (en) | 2009-11-10 | 2015-02-17 | Sangamo Biosciences, Inc. | Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases |
| US20140186340A1 (en) | 2011-04-08 | 2014-07-03 | Gilead Biologics, Inc. | Methods and Compositions for Normalization of Tumor Vasculature by Inhibition of LOXL2 |
| JP6023218B2 (ja) | 2012-01-27 | 2016-11-09 | サンバイオ，インコーポレイティド | 血管新生及び血管発生を調節するための方法及び組成物 |
| US11120889B2 (en) | 2012-05-09 | 2021-09-14 | Georgia Tech Research Corporation | Method for synthesizing a nuclease with reduced off-site cleavage |
| AU2013293062A1 (en) | 2012-07-19 | 2014-07-24 | Alethia Biotherapeutics Inc. | Anti-Siglec-15 antibodies |
| CN105408483A (zh) | 2013-03-15 | 2016-03-16 | 通用医疗公司 | 遗传和表观遗传调节蛋白至特定基因组基因座的rna引导的靶向 |
| WO2014186435A2 (en) | 2013-05-14 | 2014-11-20 | University Of Georgia Research Foundation, Inc. | Compositions and methods for reducing neointima formation |
| US11918695B2 (en) | 2014-05-09 | 2024-03-05 | Yale University | Topical formulation of hyperbranched polymer-coated particles |
| EP3721875B1 (en) | 2014-05-09 | 2023-11-08 | Yale University | Particles coated with hyperbranched polyglycerol and methods for their preparation |
| JP2019508037A (ja) | 2016-02-16 | 2019-03-28 | イェール ユニバーシティーＹａｌｅ Ｕｎｉｖｅｒｓｉｔ | 標的化遺伝子編集を増強するための組成物およびその使用方法 |
| AU2017221424A1 (en) | 2016-02-16 | 2018-09-20 | Yale University | Compositions and methods for treatment of cystic fibrosis |
| WO2017173453A1 (en) | 2016-04-01 | 2017-10-05 | The Brigham And Women's Hospital, Inc. | Stimuli-responsive nanoparticles for biomedical applications |
| US11410746B2 (en) | 2016-04-27 | 2022-08-09 | Massachusetts Institute Of Technology | Stable nanoscale nucleic acid assemblies and methods thereof |
| US11514331B2 (en) | 2016-04-27 | 2022-11-29 | Massachusetts Institute Of Technology | Sequence-controlled polymer random access memory storage |
| US11766400B2 (en) | 2016-10-24 | 2023-09-26 | Yale University | Biodegradable contraceptive implants |
| US11371023B2 (en) * | 2016-11-22 | 2022-06-28 | Wisconsin Alumni Research Foundation | Artificial transcription factors and uses thereof |
| WO2018112470A1 (en) | 2016-12-16 | 2018-06-21 | The Brigham And Women's Hospital, Inc. | Co-delivery of nucleic acids for simultaneous suppression and expression of target genes |
| WO2018187493A1 (en) | 2017-04-04 | 2018-10-11 | Yale University | Compositions and methods for in utero delivery |
| EP3612204A4 (en) | 2017-04-21 | 2021-01-27 | The General Hospital Corporation | INDUCTIBLE, TUNING AND MULTIPLEX HUMAN GENE REGULATION USING CRISPR-CPF1 |
| WO2019094928A1 (en) | 2017-11-10 | 2019-05-16 | Massachusetts Institute Of Technology | Microbial production of pure single stranded nucleic acids |
| US10953036B2 (en) | 2017-11-20 | 2021-03-23 | University Of Georgia Research Foundation, Inc. | Compositions and methods of modulating HIF-2A to improve muscle generation and repair |
| CA3100726A1 (en) | 2018-05-17 | 2019-11-21 | The General Hospital Corporation | Ccctc-binding factor variants |
| US11939593B2 (en) | 2018-08-01 | 2024-03-26 | University Of Georgia Research Foundation, Inc. | Compositions and methods for improving embryo development |
| EP3844287B1 (en) | 2018-08-31 | 2024-05-22 | Yale University | Compositions and methods for enhancing donor oligonucleotide-based gene editing |
| BR112021003823A2 (pt) | 2018-08-31 | 2021-05-25 | Yale University | composição, composição farmacêutica e método para modificar o genoma de uma célula |
| WO2020112195A1 (en) | 2018-11-30 | 2020-06-04 | Yale University | Compositions, technologies and methods of using plerixafor to enhance gene editing |
| WO2020154595A1 (en) | 2019-01-24 | 2020-07-30 | Massachusetts Institute Of Technology | Nucleic acid nanostructure platform for antigen presentation and vaccine formulations formed therefrom |
| US12642850B2 (en) | 2019-01-24 | 2026-06-02 | Massachusetts Institute Of Technology | Nucleic acid nanostructure platform for programming immune stimulation |
| US11905532B2 (en) | 2019-06-25 | 2024-02-20 | Massachusetts Institute Of Technology | Compositions and methods for molecular memory storage and retrieval |
| KR20220101073A (ko) | 2019-08-30 | 2022-07-19 | 예일 유니버시티 | 핵산을 세포로 전달하기 위한 조성물 및 방법 |
| AU2021286555B2 (en) | 2020-06-09 | 2025-04-03 | Cold Spring Harbor Laboratory | Heterozygous CENH3 monocots and methods of use thereof for haploid induction and simultaneous genome editing |
| WO2022047424A1 (en) | 2020-08-31 | 2022-03-03 | Yale University | Compositions and methods for delivery of nucleic acids to cells |
| CN117321197A (zh) | 2021-01-12 | 2023-12-29 | 马奇疗法公司 | 背景依赖性、双链dna特异性脱氨酶及其用途 |
| WO2022170117A1 (en) * | 2021-02-04 | 2022-08-11 | New York University | Seamless integration of engineered zinc fingers into endogenous transcription factors to commandeer their natural functions |
| WO2023070043A1 (en) | 2021-10-20 | 2023-04-27 | Yale University | Compositions and methods for targeted editing and evolution of repetitive genetic elements |
| WO2023192872A1 (en) | 2022-03-28 | 2023-10-05 | Massachusetts Institute Of Technology | Rna scaffolded wireframe origami and methods thereof |
| JP2025523965A (ja) | 2022-07-22 | 2025-07-25 | ザ・ジョンズ・ホプキンス・ユニバーシティー | デンドリマーが可能にする標的化細胞内ｃｒｉｓｐｒ／ｃａｓシステム送達および遺伝子編集 |
| JP2025536260A (ja) | 2022-10-11 | 2025-11-05 | イェール ユニバーシティー | 細胞透過性抗体の組成物および使用方法 |
| CN120641131A (zh) | 2022-12-01 | 2025-09-12 | 耶鲁大学 | 用于细胞内有效载荷递送的刺激反应性无痕工程化平台 |
| WO2025224715A1 (en) | 2024-04-26 | 2025-10-30 | King Abdullah Univeristy Of Science And Technology | Methods for improving precise genome modification and reducing unwanted mutations by crispr-cas editing |
| WO2026006832A1 (en) | 2024-06-28 | 2026-01-02 | University Of Connecticut | Gene modulation for treating cancer |
| WO2026122879A1 (en) | 2024-12-05 | 2026-06-11 | Massachusetts Institute Of Technology | Compositions and methods for producing endotoxin-free phage |
| WO2026128588A1 (en) | 2024-12-10 | 2026-06-18 | Yale University | Compositions and methods for treating fibrosis |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5096815A (en) * | 1989-01-06 | 1992-03-17 | Protein Engineering Corporation | Generation and selection of novel dna-binding proteins and polypeptides |
| JP3393867B2 (ja) | 1989-11-13 | 2003-04-07 | マサチユーセツツ・インステイテユート・オブ・テクノロジー | ウィルムス腫瘍遺伝子の位置決定と特徴付け |
| JP4012243B2 (ja) | 1994-01-18 | 2007-11-21 | ザ スクリップス リサーチ インスティチュート | 亜鉛フィンガータンパク質誘導体およびそのための方法 |
| CA2196419C (en) | 1994-08-20 | 2007-08-21 | Yen Choo | Improvements in or relating to binding proteins for recognition of dna |
| US5789538A (en) * | 1995-02-03 | 1998-08-04 | Massachusetts Institute Of Technology | Zinc finger proteins with high affinity new DNA binding specificities |
| US6140081A (en) | 1998-10-16 | 2000-10-31 | The Scripps Research Institute | Zinc finger binding domains for GNN |
| US6599692B1 (en) * | 1999-09-14 | 2003-07-29 | Sangamo Bioscience, Inc. | Functional genomics using zinc finger proteins |
| US7067617B2 (en) * | 2001-02-21 | 2006-06-27 | The Scripps Research Institute | Zinc finger binding domains for nucleotide sequence ANN |
| US20040224385A1 (en) * | 2001-08-20 | 2004-11-11 | Barbas Carlos F | Zinc finger binding domains for cnn |
| AU2003215094B2 (en) * | 2002-02-07 | 2008-05-29 | The Scripps Research Institute | Zinc finger libraries |
| CA2631422A1 (en) | 2005-11-28 | 2007-05-31 | The Scripps Research Institute | Zinc finger binding domains for tnn |
-
2006
- 2006-11-28 CA CA002631422A patent/CA2631422A1/en not_active Abandoned
- 2006-11-28 US US11/564,141 patent/US7833784B2/en not_active Expired - Fee Related
- 2006-11-28 EP EP06846383A patent/EP1963499A4/en not_active Ceased
- 2006-11-28 JP JP2008542539A patent/JP2009520463A/ja active Pending
- 2006-11-28 WO PCT/US2006/061289 patent/WO2007062422A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7757448B2 (ja) | 抗炎症活性を有するペプチド、及びそれを含む組成物 | |
| JP7741218B2 (ja) | 抗炎症活性を有するペプチド、及びそれを含む組成物 | |
| US8710015B2 (en) | Tropoelastin derivatives | |
| Itoh et al. | Molecular cloning and sequence determination of cDNAs for alpha subunits of the guanine nucleotide-binding proteins Gs, Gi, and Go from rat brain. | |
| Arning et al. | Mammalian splicing factor SF1 is encoded by variant cDNAs and binds to RNA. | |
| Pi et al. | Diversity and evolution of conotoxins based on gene expression profiling of Conus litteratus | |
| Ramirez et al. | Molecular characterization and evolution of a duck mitochondrial genome | |
| JP4902352B2 (ja) | トランスフォーミング増殖因子β１（ＴＧＦ−β１）との結合能を有するペプチド | |
| US20040057925A1 (en) | Methods of enhancing bioactivity of chemokines | |
| HUT70459A (en) | Analogs of pth | |
| Takahashi et al. | Evolutionarily conserved non-AUG translation initiation in NAT1/p97/DAP5 (EIF4G2) | |
| JP2026035742A5 (enExample) | ||
| Yamamoto et al. | Cloning of the cDNA encoding a novel subtype of histone H1 | |
| JP2009504156A5 (enExample) | ||
| KR20170073585A (ko) | Cd44의 단리된 폴리펩타이드 및 이의 사용 | |
| Yao et al. | Structure of the N-terminal domain of the effector protein LegC3 from Legionella pneumophila | |
| Yiu et al. | Cloning and characterization of a novel endoplasmic reticulum localized G-patch domain protein, IER3IP1 | |
| KR102307567B1 (ko) | 항염증 활성을 갖는 펩티드 및 이를 포함하는 조성물 | |
| CN107868119B (zh) | 用于抑制cd279相互作用的组合物和方法 | |
| Arakawa et al. | Molecular cloning, characterization, and chromosomal mapping of a novel human gene (GTF3A) that is highly homologous to Xenopus transcription factor IIIA | |
| Coutte et al. | Cloning and expression analysis of a cDNA that encodes a leech hemerythrin | |
| Brand et al. | Novel Drosophila melanogaster genes encoding RRM-type RNA-binding proteins identified by a degenerate PCR strategy | |
| JP2024534178A5 (enExample) | ||
| Satpathy | In silico Prediction of Anti–, SARS-CoV-2 Effect of Dermaseptin Peptides from Amphibian Origin | |
| Luo et al. | Direct cDNA cloning of novel conotoxins of the T-superfamily from Conus textile |